Impact of ventilator associated pneumonia on outcome in patients with chronic obstructive pulmonary disease exacerbation
- PMID: 24669074
- PMCID: PMC3960808
- DOI: 10.4103/0970-2113.125886
Impact of ventilator associated pneumonia on outcome in patients with chronic obstructive pulmonary disease exacerbation
Abstract
Background and objective: There are sparse data regarding the impact of ventilator-associated pneumonia (VAP) on outcome among patients with chronic obstructive pulmonary disease (COPD) exacerbation.
Materials and methods: This retrospective study included patients with COPD exacerbation requiring endotracheal intubation for more than 48 h admitted in a single respiratory unit from January 2008 to December 2009. Records of these patients were checked for the occurrence of VAP.
Results: One hundred and fifty-three patients required endotracheal intubation for COPD exacerbation during this period. The mean age of this cohort was 61.46 ± 11.3 years. The median duration of COPD was 6 years (range: 1-40). A total of 35 (22.8%) patients developed VAP (early: 9 and late: 26). The risk of mortality was comparable between two groups, that is, patients with and without VAP [odd's ratio (OR)-1.125; 95% confidence interval (CI), 0.622-2.035]. The duration of mechanical ventilation and hospital stay (median ± standard error, 95% CI) was 32 ± 10 (95% CI, 13-51) versus 10 ± 2 (95% CI, 6-14) days; P ≤ 0.001 and 53 ± 26 (95% CI, 3-103) versus 18 ± 7 (95% CI, 5-31) days; P = 0.031, respectively was higher among patients with VAP.
Conclusions: Our study has shown that VAP leads to increased duration of mechanical ventilation and hospital stay; however, the mortality is not affected.
Keywords: Chronic obstructive pulmonary disease; endotracheal intubation; in-hospital mortality; ventilator-associated pneumonia.
Conflict of interest statement
Figures
Similar articles
-
Predictors and microbiology of ventilator-associated pneumonia among patients with exacerbation of chronic obstructive pulmonary disease.Lung India. 2019 Nov-Dec;36(6):506-511. doi: 10.4103/lungindia.lungindia_13_19. Lung India. 2019. PMID: 31670298 Free PMC article.
-
Effect of chronic obstructive pulmonary disease combined with ventilator-associated pneumonia on patient outcomes: A systematic review and meta-analysis.Exp Ther Med. 2020 Dec;20(6):273. doi: 10.3892/etm.2020.9403. Epub 2020 Oct 27. Exp Ther Med. 2020. PMID: 33199998 Free PMC article.
-
Impact of ventilator-associated pneumonia on outcome in patients with COPD.Chest. 2005 Sep;128(3):1650-6. doi: 10.1378/chest.128.3.1650. Chest. 2005. PMID: 16162771
-
Chronic Obstructive Pulmonary Disease and Ventilator-Associated Pneumonia: An Analysis and Literature Review Into the Intensive Care Unit Exacerbation Progression and Acute Pulmonary Management.Dimens Crit Care Nurs. 2016 Jan-Feb;35(1):16-22. doi: 10.1097/DCC.0000000000000156. Dimens Crit Care Nurs. 2016. PMID: 26627066 Review.
-
[Ventilator-associated pneumonia and chronic obstructive pulmonary disease].Rev Mal Respir. 2007 Dec;24(10):1285-98. doi: 10.1016/s0761-8425(07)78507-8. Rev Mal Respir. 2007. PMID: 18216749 Review. French.
Cited by
-
Risk factors of ventilator-associated pneumonia in elderly patients receiving mechanical ventilation.Clin Interv Aging. 2019 Jun 7;14:1027-1038. doi: 10.2147/CIA.S197146. eCollection 2019. Clin Interv Aging. 2019. PMID: 31289438 Free PMC article.
-
Predictors and microbiology of ventilator-associated pneumonia among patients with exacerbation of chronic obstructive pulmonary disease.Lung India. 2019 Nov-Dec;36(6):506-511. doi: 10.4103/lungindia.lungindia_13_19. Lung India. 2019. PMID: 31670298 Free PMC article.
-
Myocardial injury after surgery is a risk factor for weaning failure from mechanical ventilation in critical patients undergoing major abdominal surgery.PLoS One. 2014 Nov 19;9(11):e113410. doi: 10.1371/journal.pone.0113410. eCollection 2014. PLoS One. 2014. PMID: 25409182 Free PMC article.
-
The relationship between ventilator-associated pneumonia and chronic obstructive pulmonary disease: what is the current evidence?Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):637-647. doi: 10.1007/s10096-019-03486-2. Epub 2019 Jan 24. Eur J Clin Microbiol Infect Dis. 2019. PMID: 30680576 Review.
-
Ventilator-associated pneumonia in advanced lung disease: A wakeup call.Lung India. 2014 Jan;31(1):1-3. doi: 10.4103/0970-2113.125884. Lung India. 2014. PMID: 24669073 Free PMC article. No abstract available.
References
-
- Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med. 1999;159(4 Pt 1):1249–56. - PubMed
-
- Rosenthal VD, Bijie H, Maki DG, Mehta Y, Apisarnthanarak A, Medeiros EA, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control. 2012;40:396–407. - PubMed
-
- Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, et al. VAP Outcomes Scientific Advisory Group. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122:2115–21. - PubMed
-
- Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: A prospective case-control study. Crit Care Med. 2001;29:2303–9. - PubMed
-
- Muscedere JG, Day A, Heyland DK. Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia. Clin Infect Dis. 2010;51(Suppl 1):S120–5. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources